How to Leverage Pricing Governance to Safeguard the Topline

Published on May 11, 2020
How to Leverage Pricing Governance to Safeguard the Topline Bea Doblas Mon, 05/11/2020 - 06:49pm

Body

How should pharmaceutical companies navigate the complex global pricing dynamics in the industry and stay in control of their pricing? How can companies ensure that their global pricing is aligned with the company strategy? How should companies set prices and deal with price changes in global markets, considering the impact of International Reference Pricing (IRP)? Robust pricing governance is the solution.